Forecast & Rating3 analysts currently cover Aytu BioPharma, of which 3 give a positive rating. The average price target is $9.67, about 367.0% upside from the current price of $2.07. Coverage is limited, so the data is for reference only. Data as of Sep 30, 2026; this does not constitute investment advice.
Sep 30, 2026Price forecast
$9.67366.99%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 28, 2026
Forecast met0.0%
Stock price$2.07
Avg. target$9.3
High target$13
Low target$7
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.